BCLS I Investco, LP 13D/13G Filings for X4 Pharmaceuticals, Inc. (XFOR)

BCLS I Investco, LP 13D and 13G filings for X4 Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-02-13
6:55 pm
Purchase		 2023-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BCLS I Investco, LP 16,915,784
11.000%		 4,713,274increase
(+38.63%)		 Filing
2023-02-14
06:34 am
Purchase		 2022-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BCLS I Investco, LP 12,202,510
11.000%		 9,315,968increase
(+322.74%)		 Filing
2022-02-14
06:39 am
Purchase		 2021-12-31 13G X4 Pharmaceuticals, Inc.
XFOR		 BCLS I Investco, LP 2,886,542
11.000%		 1,238,057increase
(+75.10%)		 Filing